Followers | 4219 |
Posts | 13632 |
Boards Moderated | 6 |
Alias Born | 12/14/2012 |
Monday, March 01, 2021 3:56:23 AM
With Friday's trading activity, closing unchanged at $1.14 on steady volume of 100,922 shares (the 90-day trading average is 114,866), the stock of United Health Products HAS PROVEN itself to be a STABLE INVESTMENT amongst the wider array of OTC equities that experienced sharp declines in trading last week.
This is a classic example of investors here KNOWING WHAT THEY OWN and, having done their extensive due diligence, are aware of the imminent FDA approval of HemoStyp® as a clotting agent for the more extensive use in surgical settings that will open a vastly LUCRATIVE market in the medical industry for this substantially superior hemostatic protocol.
Just a mere glance at the chart below is evidence of this stock's proven stability. Once the news hits, the price will escalate to at least $5.00, THEN the buyout negotiations from the larger pharmaceutical companies begin: THIS will be an EXCITING (and profitable) time for steadfast UEEC shareholders.
Chart: UEEC
Recent UEEC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:05:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 09:10:10 PM
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM